Context: The Supreme Court stayed a July 1, 2024 notification issued by the AYUSH Ministry in which Rule 170 of the Drugs and Cosmetics Rules, 1945 was “omitted”.
Drugs and Cosmetics Rules, 1945
o Licensing: Rule 67 outlines the conditions required for obtaining licenses to manufacture and sell drugs.
o Labeling: Rule 97 specifies the labeling requirements for drugs, ensuring proper warnings and instructions.
o Schedule G: Includes hormonal medications, anticonvulsants, and hypoglycemic drugs; labels must caution usage under medical supervision.
o Schedule H: Drugs under this schedule require a prescription for sale and must display the "Rx" symbol and a warning.
ü If a Schedule H drug is also a narcotic or psychotropic substance, it must display the "NRx" symbol.
o Schedule M: The revised Schedule M focuses on Good Manufacturing Practices (GMP) and sets standards for pharmaceutical manufacturing premises and equipment.
o Rule 170: The Rule deals with the power to take action against objectionable or misleading advertisements about Ayurvedic, Siddha, and Unani drugs.